Literature DB >> 8098183

Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome.

B D Kuppermann1, J G Petty, D D Richman, W C Mathews, S C Fullerton, L S Rickman, W R Freeman.   

Abstract

We prospectively studied 132 patients with acquired immunodeficiency syndrome (AIDS) to determine the cross-sectional prevalence of cytomegalovirus retinitis. All patients had serum CD4+ lymphocyte counts to determine the degree of immune dysfunction. Correlations between CD4+ counts, the presence of cytomegalovirus retinitis or human immunodeficiency virus (HIV)-related noninfectious retinal vasculopathy, and ocular symptoms were made. The study disclosed that 26 of 132 patients with AIDS (20%) had cytomegalovirus retinitis. However, subset analysis according to CD4+ count disclosed that in patients with CD4+ counts of 50 cells/mm3 or less, 26 of 87 (30%) had cytomegalovirus retinitis, whereas in patients with CD4+ counts of 50 cells/mm3 or more, none of 45 was noted to have cytomegalovirus retinitis. Similarly, 46 of 132 patients (35%) were noted to have HIV-related noninfectious retinal vasculopathy, with a trend toward increasing prevalence associated with declining CD4+ count. In patients with CD4+ counts of 50 cells/mm3 or less, 39 of 87 (45%) had HIV-related noninfectious retinal vasculopathy, whereas seven of 45 patients (16%) with CD4+ counts of 50 cells/mm3 or more were noted to have these changes. We confirmed the clinical impression that cytomegalovirus retinitis and HIV-related noninfectious retinal vasculopathy are late manifestations of AIDS, demonstrated an increased risk for patients with low CD4+ counts, and suggested a basis for coherent chemoprophylaxis and screening strategies for cytomegalovirus retinitis.

Entities:  

Mesh:

Year:  1993        PMID: 8098183     DOI: 10.1016/s0002-9394(14)71453-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  52 in total

Review 1.  Changing patterns of HIV related ocular disease.

Authors:  S Rauz; P I Murray
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

Review 2.  Ophthalmic manifestations of immunodeficiency states.

Authors:  R Rescigno; M Dinowitz
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

3.  Visual symptoms in patients on cyclophosphamide may herald sight threatening disease.

Authors:  A Agrawal; A D Dick; J A Olson
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

4.  Pattern of Viral Infections among Infants and Children Admitted to the Paediatric Intensive Care Unit at Sultan Qaboos University Hospital, Oman.

Authors:  Anas-Alwogud A Abdelmogheth; Alddai M A Al-Nair; Abdullah A S Balkhair; Akram M Mahmoud; Mohamed El-Naggari
Journal:  Sultan Qaboos Univ Med J       Date:  2014-10-14

5.  Synthesis and Characterization of Ganciclovir Long Chain Lipid Prodrugs.

Authors:  Kishore Cholkar; Hoang M Trinh; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Adv Ophthalmol Vis Syst       Date:  2014-08-27

6.  Comparison of three assays for cytomegalovirus detection in AIDS patients at risk for retinitis.

Authors:  P Wattanamano; J L Clayton; J J Kopicko; P Kissinger; S Elliot; C Jarrott; S Rangan; M A Beilke
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

7.  Treatment of cytomegalovirus retinitis: A growing number of options.

Authors:  S D Shafran; J M Conly
Journal:  Can J Infect Dis       Date:  1996-11

Review 8.  Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients.

Authors:  Risto S Cvetković; Keri Wellington
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Necrotising herpetic retinopathy in patients with advance HIV disease.

Authors:  R F Miller; N S Brink; J Cartledge; Y Sharvell; P Frith
Journal:  Genitourin Med       Date:  1997-12

10.  Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group.

Authors:  R D Schrier; W R Freeman; C A Wiley; J A McCutchan
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.